Seer Inc. (SEER)
1.69
0.03 (1.81%)
At close: Apr 04, 2025, 3:48 PM
1.81% (1D)
| Bid | 1.68 |
| Market Cap | 101.03M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -1.39 |
| PE Ratio (ttm) | -1.22 |
| Forward PE | -1.48 |
| Analyst | Hold |
| Ask | 1.69 |
| Volume | 426,763 |
| Avg. Volume (20D) | 223,222 |
| Open | 1.64 |
| Previous Close | 1.66 |
| Day's Range | 1.62 - 1.70 |
| 52-Week Range | 1.56 - 2.63 |
| Beta | 1.62 |
About SEER
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover...
Industry Biotechnology
Sector Healthcare
IPO Date Dec 4, 2020
Employees 134
Stock Exchange NASDAQ
Ticker Symbol SEER
Website https://seer.bio
Analyst Forecast
According to 1 analyst ratings, the average rating for SEER stock is "Hold." The 12-month stock price forecast is $3, which is an increase of 77.51% from the latest price.
Stock ForecastsNext Earnings Release
Seer Inc. is scheduled to release its earnings on May 7, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
